期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 133, 期 8, 页码 2390-2393出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja110582e
关键词
-
资金
- NIH [R01 EB 002047, HL069832]
One essential requirement for more sensitive gadolinium-based MRI contrast agents is to slow the molecular tumbling of the gadolinium(III) ion, which increases the gadolinium's relaxivity (i.e., its ability to speed up the NMR relaxation of nearby water molecules). One route to this is through conjugation to high-molecular-weight polymers such as dendrimers. In this work, amine-functionalized TREN-bis(1,2-HOPO)-TAM-ethylamine and TREN-bis(1-Me-3,2-HOPO)-TAM-ethylamine ligands have been synthesized and attached to biocompatible 40 kDa ester-amide (EA)- and poly-L-lysine (PLL)-based dendrimers capable of binding up to eight gadolinium complexes. These conjugates have T-1 relaxivities of up to 38.14 +/- 0.02 mM(-1) s(-1) per gadolinium at 37 degrees C, corresponding to relaxivities of up to 228 mM(-1) s(-1) per dendrimer molecule. This relaxivity expressed on a per Gd basis is several times that of the small-molecule complexes and an order of magnitude higher than that of current commercial agents. Because of their high performance and low toxicity, these macromolecules may constitute an attractive complement to currently available gadolinium(III)-based contrast agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据